Patent details

Basic Information

Publication number:

EP2740478

PCT Application Number:

CN2012077079

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP128225570

PCT Publication Number:

WO2013020416

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SUSTAINED-RELEASE PREPARATION OF IVABRADINE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

French Title of Invention:

PRÉPARATION À LIBÉRATION ENTRETENUE D'IVABRADINE OU DE SELS PHARMACEUTIQUEMENT ACCEPTABLES DE CELLE-CI

German Title of Invention:

PRÄPARAT MIT VERZÖGERTER FREISETZUNG VON IVABRADIN ODER PHARMAZEUTISCH UNBEDENKLICHEN SALZEN DAVON

SPC Number:

Dates

Filing date:

18/06/2012

Grant date:

01/08/2018

EP Publication Date:

11/06/2014

PCT Publication Date:

14/02/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/08/2018

EP B1 Publication Date:

01/08/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/06/2019

Expiration date:

18/06/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

25/07/2018

 

 

Name:

Jiangsu Hengrui Medicine Co., Ltd.

Address:

No. 7 Kunlunshan Road Economic and Technological Development Zone Lianyungang, Jiangsu 222047, China (CN)

Inventor

1

Name:

LIU, Kai

Address:

China (CN)

2

Name:

WU, Yuxia

Address:

China (CN)

Priority

Priority Number:

201110228902

Priority Date:

05/08/2011

Priority Country:

China (CN)

Classification

IPC classification:

A61K 31/55; A61K 47/34;

Publication

European Patent Bulletin

Issue number:

201831

Publication date:

01/08/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages